Marathon Pharmaceuticals Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 51

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 4

  • Investments
  • 4

Marathon Pharmaceuticals General Information

Description

Developer of pharmaceuticals to treat rare diseases for high need populations. The company offers non-selective central nervous system depressants that are used as sedative hypnotics, pharmaceutical for the treatment of diarrhea and pharmaceutical for the short-term treatment of insomnia and used as preanesthetic before surgery.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 1033 Skokie Boulevard
  • Suite 600
  • Northbrook, IL 60062
  • United States
Primary Industry
Pharmaceuticals
Corporate Office
  • 1033 Skokie Boulevard
  • Suite 600
  • Northbrook, IL 60062
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Marathon Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Marathon Pharmaceuticals‘s full profile, request access.

Request a free trial

Marathon Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pharmaceuticals to treat rare diseases for high need populations. The company offers non-selective central
Pharmaceuticals
Northbrook, IL
51 As of 2016

Lagos, Nigeria
 

Redwood City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Marathon Pharmaceuticals Competitors (35)

One of Marathon Pharmaceuticals’s 35 competitors is GlaxoSmithKline Consumer Nigeria, a Corporation company based in Lagos, Nigeria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GlaxoSmithKline Consumer Nigeria Corporation Lagos, Nigeria
Corcept Therapeutics Formerly VC-backed Redwood City, CA
BioMarin Pharmaceutical Formerly PE-Backed San Rafael, CA
Pfizer Pakistan Corporation Karachi, Pakistan
Camurus Corporation Lund, Sweden
You’re viewing 5 of 35 competitors. Get the full list »

Marathon Pharmaceuticals Patents

Marathon Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-5733874-A Comprising hirudin and a water-soluble salt seleccted from calcium or magnesium chloride or magnesium sulfate Inactive 26-Jan-1994
US-6436901-B1 Composition comprising hirudin, potassium phosphate and sugar, prepared by forming isotonic solution of hirudin, dipotassium hydrogen phosphate, and selected sugar at specified hirudin concentration and freeze drying solution Inactive 26-Jan-1994
US-5472938-A Sustained release formulation containing water and calcium, magnesium or zinc ions in the form of water insoluble salts Inactive 18-Feb-1993
US-6103515-A Microorganism defective in preferential proteolytic acivities; for the therapy and prophylaxis of thrombosis, shock and coagulation defects; for use as diuretic, vasorelaxant and to control cardiovascular equlibrium Inactive 04-May-1988
US-6410272-B1 Generation of huridin compounds; obtain yeast cells, transform with vectors coding huridin compounds, isolate huridin compound Inactive 12-Dec-1985 C07K14/815
To view Marathon Pharmaceuticals’s complete patent history, request access »

Marathon Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Marathon Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Marathon Pharmaceuticals‘s full profile, request access.

Request a free trial

Marathon Pharmaceuticals Investments & Acquisitions (4)

Marathon Pharmaceuticals’s most recent deal was a Early Stage VC with ReAlta Life Sciences for . The deal was made on 28-Apr-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ReAlta Life Sciences 28-Apr-2021 Early Stage VC Drug Discovery
ReAlta Life Sciences 21-Apr-2020 Early Stage VC Drug Discovery
Norphan Pharmaceuticals 01-Jan-2013 Merger/Acquisition Pharmaceuticals
Bentus Laboratories 01-Dec-2009 Later Stage VC Pharmaceuticals
To view Marathon Pharmaceuticals’s complete investments and acquisitions history, request access »

Marathon Pharmaceuticals Exits (1)

Marathon Pharmaceuticals’s most recent exit was on 01-Dec-2009 from Bentus Laboratories. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Bentus Laboratories 01-Dec-2009 Completed
  • 2 buyers
To view Marathon Pharmaceuticals’s complete exits history, request access »

Marathon Pharmaceuticals FAQs

  • Where is Marathon Pharmaceuticals headquartered?

    Marathon Pharmaceuticals is headquartered in Northbrook, IL.

  • What is the size of Marathon Pharmaceuticals?

    Marathon Pharmaceuticals has 51 total employees.

  • What industry is Marathon Pharmaceuticals in?

    Marathon Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Marathon Pharmaceuticals a private or public company?

    Marathon Pharmaceuticals is a Private company.

  • What is Marathon Pharmaceuticals’s current revenue?

    The current revenue for Marathon Pharmaceuticals is .

  • Who are Marathon Pharmaceuticals’s investors?

    Ligand Pharmaceuticals and Valor Equity Partners have invested in Marathon Pharmaceuticals.

  • Who are Marathon Pharmaceuticals’s competitors?

    GlaxoSmithKline Consumer Nigeria, Corcept Therapeutics, BioMarin Pharmaceutical, Pfizer Pakistan, and Camurus are some of the 35 competitors of Marathon Pharmaceuticals.

  • When was Marathon Pharmaceuticals acquired?

    Marathon Pharmaceuticals was acquired on 01-Oct-2015.

  • Who acquired Marathon Pharmaceuticals?

    Marathon Pharmaceuticals was acquired by CoPharma (United States).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »